In the news
WSU team publishes possible new cell marker for prostate cancer in nature's cell death and disease
August 26, 2013
An article by a team of researchers at Wayne State University's School of Medicine, Barbara Ann Karmanos Cancer Institute (KCI) and Henry Ford Hospital detailing a possible new basal cell marker in prostate cancer was selected for the Faculty of 1000 organization's F1000 Prime online directory of top articles in medicine and biology. Avraham Raz, PhD., professor of pathology, radiation oncology and oncology at the School of Medicine and KCI, is the principal investigator on the study "The significance of galectin-3 as a new basal cell marker in prostate cancer," featured in the August issue of Nature Publishing's Cell Death and Disease, an open access online peer-reviewed journal.